Lumentum has finished converting itself from a cyclical telecom-component supplier into an AI-infrastructure supplier, and fiscal 2026 is the year the numbers prove it. Revenue rose 83.2% to $3,014.0m, GAAP operating margin swung from −10.9% to +17.4%, and free cash flow turned positive at $300.1m after two years of burn. The exit rate matters more than the year: fourth-quarter revenue was $1,006.3m at a 36.6% non-GAAP operating margin, and the first quarter of fiscal 2027 is guided to $1.225–1.275bn at 39.5–40.5%.
The $6,935.1m GAAP net loss is not an operating event. It is a $7,756.6m non-cash charge from settling $1,124.9m of convertible principal in stock while the share price sat far above the conversion prices. It consumed no cash, it moved $10,443.3m into paid-in capital, and it took equity from $1,134.7m to $4,643.9m and net debt of $1,696.1m to net cash of $1,101.0m.
The risk has moved from the balance sheet to the customer list. Two customers are 41.6% of revenue and one is 30.4% of receivables, in the most capital-cycle-sensitive spending line in technology — and Lumentum has just fixed $1,159.1m of property and equipment against it.
Lumentum makes the optical and photonic parts that move data inside and between data centres: semiconductor laser chips, laser sub-assemblies, wavelength management systems, optical modules, optical circuit switches and industrial lasers. Fiscal 2026 ended 27 June 2026. From the first quarter of that year the company retired its two reportable segments — Cloud & Networking and Industrial Tech — and now reports as a single enterprise, with prior periods recast. What remains is a disaggregation by product type.
| $ millions | FY2024 | FY2025 | FY2026 | y/y | % of FY26 |
|---|---|---|---|---|---|
| Components | 822.1 | 1,116.3 | 2,005.6 | +79.7% | 66.5% |
| Systems | 537.1 | 528.7 | 1,008.4 | +90.7% | 33.5% |
| Total net revenue | 1,359.2 | 1,645.0 | 3,014.0 | +83.2% | 100.0% |
The quarterly path is the part worth memorising, because the annual figure understates where the business exited.
| Quarter | Revenue FY26 | Revenue FY25 | y/y | GAAP gross margin | GAAP operating margin | Non-GAAP gross margin | Non-GAAP operating margin | Non-GAAP EPS |
|---|---|---|---|---|---|---|---|---|
| Q1 | 533.8 | 336.9 | +58.4% | 34.0% | 1.3% | 39.4% | 18.7% | $1.10 |
| Q2 | 665.5 | 402.2 | +65.5% | 36.1% | 9.7% | 42.5% | 25.2% | $1.67 |
| Q3 | 808.4 | 425.2 | +90.1% | 44.2% | 21.6% | 47.9% | 32.2% | $2.37 |
| Q4 | 1,006.3 | 480.7 | +109.3% | 47.4% | 27.8% | 50.4% | 36.6% | $3.23 |
| Q1 FY27 guidance | 1,225–1,275 | 533.8 | ~134% | — | — | — | 39.5–40.5% | $4.05–4.35 |
Q1, Q2 and Q4 of fiscal 2025 as reported in the corresponding quarterly Form 8-K exhibits. Q3 fiscal 2025 of $425.2m is derived as the residual against the reported $1,645.0m full year. Non-GAAP operating margin expanded in every quarter of fiscal 2026 — by 650bp, 700bp and 440bp sequentially after the first.
The guidance is the analysis. A $1.25bn quarter annualises to $5.0bn against fiscal 2026's $3.01bn. Management said it is “reaching our target model more than a quarter ahead of schedule.” Simply holding the first-quarter rate flat for four quarters is a 66% year. Everything in the scenarios below is a question of what happens on top of that.
Thirteen Forms 8-K were filed between August 2025 and August 2026. Four are earnings furnishings under Item 2.02 and four concern officers and directors. The remaining five are financing events, and they are the story of the year.
| Filed | Items | Event | Detail |
|---|---|---|---|
| 2025-09-08 | 1.01, 2.03, 3.02, 8.01 | Priced $1.10bn (plus $165m option) of 0.375% convertible senior notes due 2032 at a $187.77 conversion price; entered capped call transactions; used part of the proceeds to repurchase 2026 Notes | Net proceeds $1,254.7m; capped call cost $102.0m; $843.1m of notes repaid during FY26 |
| 2025-11-04 | 2.02 | Q1 FY26 results | Revenue $533.8m, +58.4% y/y; non-GAAP EPS $1.10 |
| 2025-11-24 | 5.02, 5.07 | 2025 annual meeting voting results; officer matters | — |
| 2025-12-15 | 5.02 | Thad Trent, EVP and CFO of onsemi, appointed to the board and the audit committee | Adds audit-committee financial expertise |
| 2025-12-22 | 1.01, 2.03 | Credit Agreement dated 19 December 2025 for a senior secured revolving credit facility | $400.0m commitment with a $23.0m letter-of-credit sublimit; undrawn at year end |
| 2026-01-05 | 5.02 | Chief accounting officer transition | Matthew Sepe to retire in autumn 2026; Eric Chang appointed CAO |
| 2026-02-03 | 2.02 | Q2 FY26 results | Revenue $665.5m, +65.5% y/y; optical circuit switch backlog disclosed as “well beyond $400 million”; incremental multi-hundred-million-dollar co-packaged-optics order for the first half of calendar 2027 |
| 2026-03-02 | 3.02, 5.03, 7.01 | NVIDIA invests $2.0bn — 2,876,415 shares of Series A Convertible Preferred at $695.31 per share; certificate of designations filed; joint announcement of an optics technology partnership | Converts one-for-one into common, participates in dividends as-converted, votes with common except in director elections, no material liquidation preference |
| 2026-04-08 | 3.02 | Exchanged approximately 5.7m common shares for $264.8m of 2026 Notes and $209.7m of 2029 Notes principal plus conversion value | Incremental dilution about 0.6m shares against the original conversion terms |
| 2026-05-05 | 2.02 | Q3 FY26 results | Revenue $808.4m; non-GAAP EPS $2.37; non-GAAP operating margin 32.2% |
| 2026-06-01 | 3.02 | Exchanged approximately 5.0m common shares for $650.4m of 2028 Notes principal plus conversion value | Incremental dilution about 0.8m shares against the original conversion terms |
| 2026-07-30 | 5.02 | Vincent Retort, EVP Global Reliability and Quality, to retire in October 2026 | Two-year consulting term with continued equity vesting |
| 2026-08-11 | 2.02 | Q4 and full-year FY26 results with Q1 FY27 guidance | Q4 revenue $1,006.3m; FY26 $3,014.0m; Q1 FY27 guided to $1.225–1.275bn at a 39.5–40.5% non-GAAP operating margin |
The NVIDIA placement deserves separate weight. Two billion dollars in cash for 2,876,415 preferred shares at $695.31, announced alongside a stated partnership to develop optics technology. Because the preferred converts one-for-one, participates in dividends as-converted and carries no material preference, it is economically common stock with a transfer restriction. Two things follow: it funded the capacity build without adding debt, and it puts the ecosystem driving Lumentum's demand into Lumentum's capital structure. That is concentration expressed a second way — the same customer base now sits on both sides of the balance sheet.
| $ millions unless stated | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Income statement | |||||
| Net revenue | 1,712.6 | 1,767.0 | 1,359.2 | 1,645.0 | 3,014.0 |
| Revenue growth | — | 3.2% | -23.1% | 21.0% | 83.2% |
| Gross profit | 788.6 | 569.0 | 251.5 | 459.9 | 1,255.9 |
| Gross margin | 46.0% | 32.2% | 18.5% | 28.0% | 41.7% |
| Research and development | 220.7 | 307.8 | 302.2 | 303.9 | 356.5 |
| Selling, general and administrative | 265.7 | 348.8 | 310.7 | 348.2 | 363.2 |
| Restructuring and related | -1.1 | 28.1 | 72.6 | 22.8 | 11.4 |
| Operating income (loss) | 303.3 | -115.7 | -434.0 | -180.1 | 524.8 |
| Operating margin | 17.7% | -6.5% | -31.9% | -10.9% | 17.4% |
| Loss on debt extinguishment | — | — | — | — | -7,756.6 |
| Income tax expense (benefit) | 36.2 | 29.2 | 140.8 | -198.0 | -237.7 |
| Net income (loss), GAAP | 198.9 | -131.6 | -546.5 | 25.9 | -6,935.1 |
| Net margin | 11.6% | -7.4% | -40.2% | 1.6% | -230.1% |
| Net income ex-extinguishment | 198.9 | -131.6 | -546.5 | 25.9 | 821.5 |
| Diluted EPS ($) | 2.68 | -1.93 | -8.12 | 0.37 | -92.96 |
| Diluted shares (m) | 74.2 | 68.3 | 67.3 | 69.6 | 74.6 |
| Cash flow and capital intensity | |||||
| EBITDA | 470.4 | 139.9 | -143.7 | 76.6 | 791.8 |
| EBITDA margin | 27.5% | 7.9% | -10.6% | 4.7% | 26.3% |
| Cash from operations | 459.3 | 179.8 | 24.7 | 126.3 | 751.4 |
| Capital expenditure | 91.2 | 128.5 | 133.0 | 231.0 | 451.3 |
| Capex % of revenue | 5.3% | 7.3% | 9.8% | 14.0% | 15.0% |
| Free cash flow | 368.1 | 51.3 | -108.3 | -104.7 | 300.1 |
| FCF margin | 21.5% | 2.9% | -8.0% | -6.4% | 10.0% |
| Stock-based compensation | 103.1 | 148.4 | 128.8 | 177.2 | 170.2 |
| Balance sheet | |||||
| Cash and short-term investments | 2,549.0 | 2,013.6 | 887.0 | 877.1 | 2,738.4 |
| Accounts receivable | 262.0 | 246.1 | 194.7 | 250.0 | 520.3 |
| Inventory | 250.1 | 408.6 | 398.4 | 470.1 | 691.6 |
| Property, plant and equipment, net | 360.5 | 489.5 | 572.5 | 726.4 | 1,159.1 |
| Total assets | 4,162.2 | 4,632.1 | 3,931.9 | 4,218.7 | 7,307.5 |
| Accounts payable | 156.7 | 169.4 | 126.3 | 225.2 | 567.4 |
| Total debt | 1,876.0 | 2,811.6 | 2,503.2 | 2,573.2 | 1,637.4 |
| Net debt (cash) | -673.0 | 798.0 | 1,616.2 | 1,696.1 | -1,101.0 |
| Stockholders' equity | 1,875.0 | 1,355.8 | 957.3 | 1,134.7 | 4,643.9 |
Fiscal years end on the Saturday closest to 30 June. Sourced from the fiscal 2026 Form 10-K for FY2024–FY2026, the fiscal 2024 Form 10-K for FY2022–FY2024 and the fiscal 2023 Form 10-K for the FY2022 balance sheet. EBITDA is operating income plus depreciation plus amortisation of acquired intangibles. Free cash flow is cash from operations less purchases of property, plant and equipment. Net debt is total debt less cash and short-term investments; negative figures are net cash. Net income ex-extinguishment adds back the $7,756.6m non-cash charge and makes no other adjustment — it still contains the $236.3m valuation-allowance release.
The five years contain a complete cycle. Fiscal 2022 was the prior peak. Fiscal 2023 and 2024 were the inventory correction: revenue fell 23.1% in fiscal 2024, gross margin compressed to 18.5%, and operating margin reached −31.9% as fixed costs sat against collapsing volume. Fiscal 2025 was the turn, and fiscal 2026 the vertical part.
What makes fiscal 2026 unusual is how little of the recovery came from spending restraint reversing. Operating expenses in absolute dollars rose only 6.7% from the fiscal 2024 trough to fiscal 2026 — $685.5m to $731.1m — while revenue more than doubled. That is the whole operating-leverage story in two numbers.
| Operating leverage, FY25 to FY26 | $m | Margin effect |
|---|---|---|
| Volume: revenue growth at the FY25 gross margin | 382.7 | — |
| Price, mix and absorption | 413.3 | +1,370bp |
| Gross profit increase | 796.0 | — |
| R&D increase (+17.3%) | (52.6) | +670bp |
| SG&A increase (+4.3%) | (15.0) | +910bp |
| Restructuring decrease | 11.4 | +100bp |
| Prior-year facility gain not repeated | (34.9) | −210bp |
| Operating income increase | 704.9 | +2,830bp |
Slightly more than half of the gross-profit increase came from price, mix and absorption rather than volume. And selling, general and administrative expense grew 4.3% against 83.2% revenue growth — that single line delivered 910bp of the 2,830bp operating-margin swing.
| $ millions unless stated | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 46.0% | 32.2% | 18.5% | 28.0% | 41.7% |
| Operating margin | 17.7% | -6.5% | -31.9% | -10.9% | 17.4% |
| EBITDA margin | 27.5% | 7.9% | -10.6% | 4.7% | 26.3% |
| Net margin, GAAP | 11.6% | -7.4% | -40.2% | 1.6% | -230.1% |
| Net margin ex-extinguishment | 11.6% | -7.4% | -40.2% | 1.6% | 27.3% |
| R&D as % of revenue | 12.9% | 17.4% | 22.2% | 18.5% | 11.8% |
| SG&A as % of revenue | 15.5% | 19.7% | 22.9% | 21.2% | 12.1% |
| Total operating expense as % of revenue | 28.3% | 38.7% | 50.4% | 38.9% | 24.3% |
| Returns | |||||
| Return on equity, GAAP | 10.6% | -8.1% | -47.3% | 2.5% | -240.0% |
| Return on equity ex-extinguishment | 10.6% | -8.1% | -47.3% | 2.5% | 28.4% |
| Return on assets, GAAP | 4.8% | -3.0% | -12.8% | 0.6% | -120.3% |
| ROIC (NOPAT at 16.5% / avg. invested capital) | 21.1% | -5.8% | -15.3% | -5.6% | 13.8% |
| Liquidity | |||||
| Current ratio (x) | 4.38 | 4.38 | 5.90 | 4.37 | 1.68 |
| Quick ratio (x) | 3.92 | 3.57 | 4.02 | 2.87 | 1.31 |
| Working capital | 2,422.7 | 2,144.1 | 1,320.8 | 1,324.5 | 1,681.4 |
| Leverage and coverage | |||||
| Debt / equity (x) | 1.00 | 2.07 | 2.61 | 2.27 | 0.35 |
| Debt / total assets | 45.1% | 60.7% | 63.7% | 61.0% | 22.4% |
| Net debt / EBITDA (x) | -1.4 | 5.7 | — | 22.1 | -1.4 |
| EBIT / interest expense (x) | 3.8 | -3.3 | -12.8 | -8.1 | 24.1 |
| Equity / total assets | 45.0% | 29.3% | 24.3% | 26.9% | 63.5% |
| Working-capital efficiency | |||||
| Days sales outstanding | 55.8 | 52.5 | 59.2 | 49.3 | 46.6 |
| Days inventory outstanding | 98.8 | 100.3 | 133.0 | 133.7 | 120.6 |
| Days payable outstanding | 61.9 | 49.7 | 48.7 | 54.1 | 82.3 |
| Cash conversion cycle (days) | 92.7 | 103.1 | 143.4 | 129.0 | 85.0 |
| Inventory turns (x) | 3.7 | 3.6 | 2.7 | 2.7 | 3.0 |
| Asset turnover (x) | 0.41 | 0.40 | 0.32 | 0.40 | 0.52 |
| PP&E turnover (x) | 4.75 | 4.16 | 2.56 | 2.53 | 3.20 |
Balance-sheet denominators use two-year averages where a prior year is available. ROIC applies the company's stated 16.5% long-term non-GAAP tax rate to GAAP operating income over average invested capital, defined as total debt plus equity less cash and short-term investments. Net debt to EBITDA is not meaningful in fiscal 2024 on negative EBITDA and is negative in fiscal 2022 and 2026, both net-cash years.
Five things stand out.
One ratio is a false alarm. The current ratio of 1.68x looks like a liquidity deterioration and is not. It is a classification effect: $1,596.9m of convertible notes moved into current liabilities because the share price closed above 130% of every conversion price for 20 of the last 30 trading days of the fiscal year, making all four series convertible at holder option. Cash and short-term investments of $2,738.4m cover the entire principal.
A company growing 83% with a 30% operating margin has to be read against its sector, because in optics both of those numbers are cyclical rather than structural. Four listed comparables, each at its own most recent completed fiscal year.
| Company | Latest FY | Growth | Margins | Cash | Returns | Efficiency | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $m | y/y | 2-yr CAGR | Gross | Operating | Net | R&D % | CFO $m | Capex $m | FCF $m | ROE | Net debt / equity | Inventory turns | DSO | Asset turnover | ||
| Lumentum (GAAP) | FY26 Jun-26 | 3,014 | 83.2% | 48.9% | 41.7% | 17.4% | −230.1% | 11.8% | 751 | 451 | 300 | −240.0% | −0.24 | 3.0 | 47 | 0.52 |
| Lumentum (non-GAAP) | FY26 Jun-26 | 3,014 | 83.2% | 48.9% | 46.0% | 29.8% | 26.0% | 10.1% | 751 | 451 | 300 | 28.4% | −0.24 | 3.0 | 47 | 0.52 |
| Coherent | FY26 Jun-26 | 7,118 | 22.5% | 23.0% | 37.5% | 10.9% | 11.3% | 10.2% | 80 | 1,103 | −1,023 | 9.7% | 0.11 | 2.2 | 59 | 0.43 |
| Fabrinet | FY26 Jun-26 | 4,641 | 35.7% | 26.9% | 12.0% | 10.0% | 10.2% | n/d | 257 | 252 | 4 | 21.3% | −0.36 | 5.1 | 70 | 1.38 |
| Ciena | FY25 Nov-25 | 4,770 | 18.8% | 4.3% | 42.0% | 4.1% | 2.6% | 17.8% | 806 | 141 | 665 | 4.4% | 0.08 | 3.4 | 72 | 0.83 |
| Applied Optoelectronics | CY25 Dec-25 | 456 | 82.7% | 44.7% | 30.0% | −12.0% | −8.4% | 18.8% | −174 | 179 | −354 | −7.9% | −0.06 | 2.4 | 145 | 0.53 |
All figures from SEC XBRL. Coherent gross profit and operating income are derived — revenue less cost of goods sold, then less R&D, SG&A, restructuring and impairment — because Coherent presents neither subtotal; the derivation reconciles exactly to reported pre-tax income. Coherent return on equity uses net income attributable to Coherent over average total shareholders' equity, a period spanning the fiscal 2026 Series B preferred conversion. Fabrinet does not disclose R&D separately. Peer ratios use ending balances rather than the two-year averages applied to Lumentum elsewhere, so they are directionally comparable rather than identical in method.
Capacity is being added industry-wide, not only at Lumentum. $2.1bn of combined capital expenditure in a single year against a combined revenue base of $20.0bn. If AI optical demand grows into it, the supply constraint eases and pricing normalises — which caps the optimistic gross margin below what the 50.4% fourth quarter might suggest on its own. If demand pauses, five companies de-absorb simultaneously, which is what makes the downside a margin event rather than only a revenue event.
The margin premium is a mix and vertical-integration premium, and it is contestable. Coherent has the larger indium phosphide and laser-chip franchise and 2.4x the revenue over which to amortise engineering. Lumentum's R&D at 11.8% of revenue is the lowest point in its own five-year range, and in absolute dollars Coherent outspends it roughly two to one, $723.0m against $356.5m. Sustaining a 40%-plus operating margin against that is the central assumption of the optimistic cases below.
The differentiated products have no direct listed comparable. Optical circuit switches and co-packaged-optics laser sources are where Lumentum's disclosed backlog and orders sit, and neither Coherent nor Fabrinet reports a competing line. That is the structural reason the bull case can carry a higher margin than the sector.
Cycle position. Fiscal 2023 to 2024 was a full inventory correction across this group: Lumentum revenue −23.1%, Ciena −8.5% in its fiscal 2024, Applied Optoelectronics operating margin −19.0% in calendar 2023. The current up-cycle is roughly eight quarters old. The historical precedent for what follows an eight-quarter optical up-cycle is not a plateau.
| Convertible notes at 27 June 2026 | Coupon | Maturity | Carrying $m | Fair value $m | Conversion price |
|---|---|---|---|---|---|
| 2032 Notes | 0.375% | 15-Mar-32 | 1,256.1 | 5,411.1 | $187.77 |
| 2029 Notes | 1.500% | 15-Dec-29 | 54.7 | 640.2 | $69.54 |
| 2028 Notes | 0.500% | 15-Jun-28 | 179.1 | 1,108.7 | $131.03 |
| 2026 Notes | 0.500% | 15-Dec-26 | 54.7 | 447.2 | $99.29 |
| Total | — | — | 1,544.6 | 7,607.2 | — |
Lumentum exchanged roughly 10.7m common shares for $1,124.9m of convertible principal plus the conversion value above it. Under US GAAP the fair value of shares delivered in excess of the carrying amount of the debt is a loss on extinguishment. Because the share price had risen far above conversion prices set between $69.54 and $187.77, that excess was $7.8bn.
Nothing about it is an operating or a cash event. The mirror entry is a $10,443.3m increase in additional paid-in capital. The economic substance is dilution — about 10.7m shares, of which only 1.4m were incremental to what the original conversion terms would have required — not value destruction. Cash interest paid during the year was $15.7m.
The one place the charge had a real effect. It created a cumulative three-year US pre-tax loss, which under ASC 740 is negative evidence against recognising deferred tax assets. Management had to construct an objectively verifiable forecast of future US taxable income excluding the extinguishment in order to release $236.3m of valuation allowance in the fourth quarter. That release sits inside the $237.7m reported tax benefit and inside the $821.5m of ex-extinguishment net income. It is non-recurring and should not be carried into forward estimates. The stated long-term non-GAAP tax rate is 16.5%, and an $81.4m valuation allowance remains against federal foreign tax credit and California R&D credit carryforwards.
| Reported non-GAAP bridge, $m except per share | FY2025 | FY2026 |
|---|---|---|
| GAAP net income (loss) | 25.9 | (6,935.1) |
| Loss on debt extinguishment | — | 7,756.6 |
| Stock-based compensation and related payroll tax | 177.2 | 191.3 |
| Amortisation of acquired intangibles | 149.7 | 135.7 |
| Restructuring, write-offs, FX, inducement, other | 19.3 | 43.5 |
| Escrow settlement and acquisition items | 1.2 | (17.4) |
| Non-GAAP tax reconciling adjustments | (226.9) | (392.3) |
| Non-GAAP net income | 146.4 | 782.3 |
| Non-GAAP diluted EPS | $2.06 | $8.67 |
| Non-GAAP diluted shares (m) | 71.2 | 90.2 |
| Adjusted EBITDA | 264.2 | 1,025.8 |
Non-GAAP diluted shares of 90.2m include about 13.6m from assumed conversion of the notes, net of 0.8m from the capped call. Shares outstanding at year end were 88.6m common plus 2.9m preferred, or 91.5m as-converted, against 69.8m a year earlier — a 31.1% increase in the share count. All four note series remained convertible at holder option entering the first quarter of fiscal 2027, principal must be settled in cash, and as of 14 August 2026 the company had received early conversion requests for $757.8m of principal.
Six factors, ordered by how much revenue each can add and how well each is evidenced in the filings rather than in commentary.
Modelled on a non-GAAP basis, consistent with how Lumentum guides. Non-GAAP excludes stock-based compensation and related payroll taxes of $191.3m, amortisation of acquired intangibles of $135.7m, restructuring, and the extinguishment charge. Operating expense is built in dollars rather than as a percentage of revenue, so the operating-leverage assumption is explicit and testable rather than buried in a ratio.
The base year is fiscal 2026: revenue $3,014.0m, non-GAAP gross margin 46.0%, non-GAAP operating expense $489.7m, non-GAAP operating income $897.0m, adjusted EBITDA $1,025.8m, depreciation $128.8m, capital expenditure $451.3m.
Bull 57% three-year revenue CAGR
| $ millions | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Net revenue | 5,810 | 8,715 | 11,760 |
| y/y growth | 92.8% | 50.0% | 34.9% |
| Gross margin | 52.5% | 54.5% | 55.5% |
| Operating expense | 660 | 850 | 1,050 |
| Operating income | 2,390 | 3,900 | 5,477 |
| Operating margin | 41.1% | 44.7% | 46.6% |
| Adj. EBITDA | 2,600 | 4,220 | 5,917 |
| Cash from operations | 1,716 | 3,038 | 4,615 |
| Capital expenditure | 872 | 1,133 | 1,411 |
| Free cash flow | 845 | 1,905 | 3,204 |
| FCF margin | 14.5% | 21.9% | 27.2% |
| Cumulative 3-yr FCF | 845 | 2,750 | 5,954 |
Base 41% three-year revenue CAGR
| $ millions | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Net revenue | 5,390 | 7,005 | 8,405 |
| y/y growth | 78.8% | 30.0% | 20.0% |
| Gross margin | 51.5% | 52.0% | 52.0% |
| Operating expense | 640 | 780 | 900 |
| Operating income | 2,136 | 2,863 | 3,471 |
| Operating margin | 39.6% | 40.9% | 41.3% |
| Adj. EBITDA | 2,326 | 3,133 | 3,821 |
| Cash from operations | 1,675 | 2,443 | 3,133 |
| Capital expenditure | 701 | 771 | 840 |
| Free cash flow | 974 | 1,673 | 2,292 |
| FCF margin | 18.1% | 23.9% | 27.3% |
| Cumulative 3-yr FCF | 974 | 2,647 | 4,939 |
Bear 9% three-year revenue CAGR
| $ millions | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Net revenue | 4,700 | 4,000 | 3,900 |
| y/y growth | 55.9% | -14.9% | -2.5% |
| Gross margin | 48.0% | 41.0% | 38.0% |
| Operating expense | 620 | 640 | 620 |
| Operating income | 1,636 | 1,000 | 862 |
| Operating margin | 34.8% | 25.0% | 22.1% |
| Adj. EBITDA | 1,816 | 1,230 | 1,112 |
| Cash from operations | 1,453 | 1,107 | 1,056 |
| Capital expenditure | 564 | 280 | 195 |
| Free cash flow | 889 | 827 | 861 |
| FCF margin | 18.9% | 20.7% | 22.1% |
| Cumulative 3-yr FCF | 889 | 1,716 | 2,577 |
| Driver | Bull | Base | Bear |
|---|---|---|---|
| FY27 revenue path | Sequential growth of 9–10% a quarter from the $1.25bn guided first quarter; $5,810m | Sequential growth of about 5% a quarter from the same starting point; $5,390m | First quarter delivered as guided, then sequential decline; $4,700m |
| FY28–FY29 revenue | +50%, +34.9% as optical circuit switches and co-packaged optics both reach volume production | +30%, +20%; normal deceleration as the base grows | −14.9%, −2.5%; one hyperscaler digestion cycle, as in fiscal 2024 |
| Gross margin | 52.5% rising to 55.5%; proprietary switch and co-packaged-optics mix carries price | 51.5% to 52.0%; holds near the 50.4% fourth-quarter exit rate | 48.0% falling to 38.0%; under-absorption on the enlarged asset base |
| Operating expense | $660m to $1,050m; about +20% a year, R&D-led | $640m to $900m; about +16% a year off the $552m annualised fourth-quarter run rate | $620m held flat, with a modest cut in the final year |
| Capital expenditure | 15% falling to 12% of revenue; the capacity chase continues | 13% to 10% of revenue; normalises toward maintenance plus growth | 12% to 5% of revenue; programme cuts, as in fiscal 2023 |
| EBITDA-to-cash conversion | 66% rising to 78%; heavy working-capital build ahead of revenue | 72% to 82%; fiscal 2026 actual was 73% | 80% to 95%; working capital releases on the way down |
| Not modelled | Acquisitions; buybacks; interest income on the $2.7bn cash balance; cash settlement of convertible principal of up to $1,554.3m, of which $757.8m had already been requested by 14 August 2026; tax, since the 16.5% long-term non-GAAP rate applies below the operating line. | ||
Two grids, both for fiscal 2029, crossing revenue against the non-GAAP operating margin. The rows span the bear, base and bull revenue outcomes; the columns span their margins.
| Revenue / operating margin | 22% | 28% | 34% | 41% | 46% |
|---|---|---|---|---|---|
| 3,900 | 858 | 1,092 | 1,326 | 1,599 | 1,794 |
| 5,000 | 1,100 | 1,400 | 1,700 | 2,050 | 2,300 |
| 6,500 | 1,430 | 1,820 | 2,210 | 2,665 | 2,990 |
| 8,405 | 1,849 | 2,353 | 2,858 | 3,446 | 3,866 |
| 10,000 | 2,200 | 2,800 | 3,400 | 4,100 | 4,600 |
| 11,760 | 2,587 | 3,293 | 3,998 | 4,822 | 5,410 |
| Revenue / operating margin | 22% | 28% | 34% | 41% | 46% |
|---|---|---|---|---|---|
| 3,900 | 513 | 696 | 878 | 1,091 | 1,243 |
| 5,000 | 592 | 826 | 1,060 | 1,333 | 1,528 |
| 6,500 | 699 | 1,004 | 1,308 | 1,663 | 1,916 |
| 8,405 | 836 | 1,229 | 1,623 | 2,081 | 2,409 |
| 10,000 | 950 | 1,418 | 1,886 | 2,432 | 2,822 |
| 11,760 | 1,076 | 1,626 | 2,177 | 2,819 | 3,277 |
The free-cash-flow grid holds depreciation at $300m, EBITDA-to-cash conversion at 78% and capital expenditure at 10% of revenue in every cell, so it isolates the revenue and margin effect alone. Each scenario table above uses its own conversion and capital-expenditure assumptions instead.
Six observable things, each of which resolves before the fiscal 2029 outcome is knowable.
All historical figures are as reported in SEC XBRL, unsegmented facts, retrieved through the sec-api.io API. No restatements were applied. Ratios are computed here rather than taken from the filings.
Three caveats worth stating plainly. First, revenue by geography is assigned to where product first ships, which for most cloud customers is a contract manufacturer rather than the end customer — Mexico revenue grew 199% and Thailand 115% in fiscal 2026, and neither is end demand by country. Second, fiscal 2025 third-quarter revenue of $425.2m is derived as the residual of the reported full year less the three quarters disclosed in 8-K exhibits; every other figure is as reported. Third, this analysis carries no valuation, no multiple and no price target, because doing so would require market data that cannot be verified against the filings themselves.
Scenario figures are estimates built on the stated assumptions. They are not forecasts, they are not company guidance beyond the first-quarter fiscal 2027 range published on 11 August 2026, and they are not investment advice. Prepared 27 August 2026, before any fiscal 2027 Form 10-Q was filed.